Azra AI

Azra AI

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://www.azra-ai.com

Last Round

Series A

Jul 8, 2025

Momentum Score

25 /100

Company Overview

Azra AI is a health-tech company that provides an AI-powered software platform for the oncology sector. The company's solution analyzes unstructured data from pathology and radiology reports to identify cancer diagnoses and incidental findings in real-time, enabling healthcare providers to accelerate patient identification and treatment. Used by numerous hospitals and cancer centers, the end-to-end platform automates oncology workflows and helps manage the complete patient journey from initial suspicion through survivorship, aiming to improve patient outcomes and operational efficiency.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Workflow Automation, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

oncology workflow automationcancer registry automationcancer patient identificationclinical AIincidental findings detectionnatural language processingNLPpathology report analysisradiology report analysisclinical decision supportEHR integrationnurse navigator toolstumor board softwareHealthTechenterprise SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Azra AI Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Azra AI Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJul 8, 2025

Key People

Founding team and executive leadership

Chris Cashwell

Chief Executive Officer

Executive Team

John Marshall

Chief Executive Officer

Executive Team

Azra AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    Acquired Thynk Health, a leader in lung cancer screening and incidental findings management.

  • Jul 8, 2025

    $8M round with participation from FCA Venture Partners and NewHealth Ventures.

Azra AI Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Azra AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Azra AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range51
Year Founded2021
Last FundingJul 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.